Tuagon, Mark Jade P.

HRN: 19-96-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
01/20/2023
01/24/2023
PO
2.7ml
OD
PCAP C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: